VYNE Therapeutics
VYNE
VYNE
41 hedge funds and large institutions have $1.1M invested in VYNE Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 16 reducing their positions, and 4 closing their positions.
Holders
41
Holders Change
–
Holders Change %
0%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
16
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Millennium Management
New York
|
$73K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$8.2K |
3 |
TSS
3
Two Sigma Securities
New York
|
$2.84K |
4 |
MLA
4
MB, Levis & Associates
Center Valley,
Pennsylvania
|
$2.81K |
5 |
SG
5
StoneX Group
New York
|
$2.08K |
Top Sellers
1 |
DA
1
DSC Advisors
Chicago,
Illinois
|
$236K |
2 |
VF
2
Virtu Financial
New York
|
$0 |
3 |
3
Renaissance Technologies
New York
|
$130K |
4 |
4
Citadel Advisors
Miami,
Florida
|
$8.09K |
5 |
5
Jane Street
New York
|
$2.77K |